{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:44:53Z","timestamp":1780505093894,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100836"],"award-info":[{"award-number":["82100836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272850"],"award-info":[{"award-number":["82272850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202201011532"],"award-info":[{"award-number":["202201011532"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010596"],"award-info":[{"award-number":["2024A1515010596"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Development Center for Medical Science & Technology National Health Commission of the People's Republic of China","award":["WKZX2023CX130001"],"award-info":[{"award-number":["WKZX2023CX130001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11010-025-05328-6","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:21:41Z","timestamp":1750663301000},"page":"5485-5500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["High IGFL2 regulates ovarian cancer progression and the tumor immune microenvironment via the Warburg effect"],"prefix":"10.1007","volume":"480","author":[{"given":"Zhizai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"1","key":"5328_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"5328_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"D Tan","year":"2006","unstructured":"Tan D, Agarwal R, Kaye S (2006) Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 7(11):925\u2013934","journal-title":"Lancet Oncol"},{"issue":"2","key":"5328_CR3","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y (2021) Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer 1875(2):188503","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"5328_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"N Pavlova","year":"2016","unstructured":"Pavlova N, Thompson C (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27\u201347","journal-title":"Cell Metab"},{"key":"5328_CR5","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368:6487","journal-title":"Science"},{"key":"5328_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-016-0145-9","volume":"4","author":"AM Otto","year":"2016","unstructured":"Otto AM (2016) Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab 4:5","journal-title":"Cancer Metab"},{"issue":"3","key":"5328_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211\u2013218","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"5328_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G (2021) Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol 599(6):1745\u20131757","journal-title":"J Physiol"},{"key":"5328_CR9","doi-asserted-by":"crossref","unstructured":"Li J, Zheng C, Mai Q, Huang X, Pan W, Lu J, et al (2023) Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer. Cell Metab 35(11)","DOI":"10.1016\/j.cmet.2023.10.002"},{"key":"5328_CR10","doi-asserted-by":"crossref","unstructured":"Li J, Lu J, Xu M, Yang S, Yu T, Zheng C, et al (2023) ODF2L acts as a synthetic lethal partner with WEE1 inhibition in epithelial ovarian cancer models. J Clin Investig 133(2)","DOI":"10.1172\/JCI161544"},{"issue":"8","key":"5328_CR11","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41388-021-02149-x","volume":"41","author":"J Li","year":"2022","unstructured":"Li J, Zheng C, Wang M, Umano AD, Dai Q, Zhang C et al (2022) ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer. Oncogene 41(8):1114\u20131128","journal-title":"Oncogene"},{"key":"5328_CR12","doi-asserted-by":"crossref","unstructured":"Xu M, Huang X, Zheng C, Long J, Dai Q, Chen Y, et al (2022) Platinum-resistant ovarian cancer is vulnerable to the cJUN-XRCC4 pathway inhibition. Cancers (Basel) 14(24)","DOI":"10.3390\/cancers14246068"},{"issue":"11","key":"5328_CR13","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1172\/JCI87252","volume":"126","author":"M Yin","year":"2016","unstructured":"Yin M, Li X, Tan S, Zhou H, Ji W, Bellone S et al (2016) Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Investig 126(11):4157\u20134173","journal-title":"J Clin Investig"},{"issue":"1","key":"5328_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol 12(1):76","journal-title":"J Hematol Oncol"},{"issue":"2","key":"5328_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","volume":"77","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang Z, Bao R, Guo X, Gu Y, Yang W et al (2022) Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. J Hepatol 77(2):453\u2013466","journal-title":"J Hepatol"},{"issue":"7970","key":"5328_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06256-5","volume":"619","author":"X Zhang","year":"2023","unstructured":"Zhang X, Li S, Malik I, Do MH, Ji L, Chou C et al (2023) Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature 619(7970):616\u2013623","journal-title":"Nature"},{"issue":"1","key":"5328_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2013.01.042","volume":"341","author":"ML Taddei","year":"2013","unstructured":"Taddei ML, Giannoni E, Comito G, Chiarugi P (2013) Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett 341(1):80\u201396","journal-title":"Cancer Lett"},{"issue":"2","key":"5328_CR18","doi-asserted-by":"publisher","first-page":"188361","DOI":"10.1016\/j.bbcan.2020.188361","volume":"1873","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Wang C, Zhou S (2020) Targeting tumor microenvironment in ovarian cancer: premise and promise. Biochim Biophys Acta Rev Cancer 1873(2):188361","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10","key":"5328_CR19","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.yexcr.2013.02.017","volume":"319","author":"A Anderson","year":"2013","unstructured":"Anderson A, Roberts P, Frisard M, McMillan R, Brown T, Lawless M et al (2013) Metabolic changes during ovarian cancer progression as targets for sphingosine treatment. Exp Cell Res 319(10):1431\u20131442","journal-title":"Exp Cell Res"},{"issue":"1","key":"5328_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","volume":"29","author":"S-C Lin","year":"2022","unstructured":"Lin S-C, Liao Y-C, Chen P-M, Yang Y-Y, Wang Y-H, Tung S-L et al (2022) Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling. J Biomed Sci 29(1):109","journal-title":"J Biomed Sci"},{"key":"5328_CR21","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.2147\/CMAR.S176152","volume":"10","author":"B Zou","year":"2018","unstructured":"Zou B, Liu X, Gong Y, Cai C, Li P, Xing S et al (2018) A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma. Cancer Manag Res 10:5303\u20135311","journal-title":"Cancer Manag Res"},{"issue":"1","key":"5328_CR22","first-page":"175","volume":"41","author":"M Chi","year":"2022","unstructured":"Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X et al (2022) TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer. J Exp Clin Cancer Res CR 41(1):175","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"1","key":"5328_CR23","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1038\/s41598-023-27602-7","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yuan H, Yue G, Zhao L, Xia Y, Zhang N et al (2023) Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy. Sci Rep 13(1):6034","journal-title":"Sci Rep"},{"issue":"3","key":"5328_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053\u20131064","journal-title":"Am J Pathol"},{"key":"5328_CR25","doi-asserted-by":"crossref","unstructured":"Uruski P, Miku\u0142a-Pietrasik J, Paku\u0142a M, Budkiewicz S, Drzewiecki M, Gaiday AN, et al (2021) Malignant ascites promote adhesion of ovarian cancer cells to peritoneal mesothelium and fibroblasts. Int J Mol Sci 22(8)","DOI":"10.3390\/ijms22084222"},{"key":"5328_CR26","doi-asserted-by":"crossref","unstructured":"Uno K, Iyoshi S, Yoshihara M, Kitami K, Mogi K, Fujimoto H, et al (2022) Metastatic voyage of ovarian cancer cells in ascites with the assistance of various cellular components. Int J Mol Sci 23(8)","DOI":"10.3390\/ijms23084383"},{"key":"5328_CR27","doi-asserted-by":"publisher","first-page":"121728","DOI":"10.1016\/j.biomaterials.2022.121728","volume":"288","author":"LI Ibrahim","year":"2022","unstructured":"Ibrahim LI, Hajal C, Offeddu GS, Gillrie MR, Kamm RD (2022) Omentum-on-a-chip: a multicellular, vascularized microfluidic model of the human peritoneum for the study of ovarian cancer metastases. Biomaterials 288:121728","journal-title":"Biomaterials"},{"key":"5328_CR28","doi-asserted-by":"crossref","unstructured":"Fukushi A, Kim H-D, Chang Y-C, Kim C-H (2022) Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells. Int J Mol Sci 23(17)","DOI":"10.3390\/ijms231710037"},{"issue":"5","key":"5328_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5):325\u2013337","journal-title":"Nat Rev Cancer"},{"issue":"5930","key":"5328_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033","journal-title":"Science"},{"key":"5328_CR31","doi-asserted-by":"crossref","unstructured":"Icard P, Shulman S, Farhat D, Steyaert J-M, Alifano M, Lincet H (2018) How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat 38","DOI":"10.1016\/j.drup.2018.03.001"},{"issue":"8","key":"5328_CR32","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA (2022) The complex role of tumor-infiltrating macrophages. Nat Immunol 23(8):1148\u20131156","journal-title":"Nat Immunol"},{"issue":"39","key":"5328_CR33","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.2174\/0929867328666210720143721","volume":"28","author":"S Dallavalasa","year":"2021","unstructured":"Dallavalasa S, Beeraka NM, Basavaraju CG, Tulimilli SV, Sadhu SP, Rajesh K et al (2021) The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis\u2014current status. Curr Med Chem 28(39):8203\u20138236","journal-title":"Curr Med Chem"},{"key":"5328_CR34","doi-asserted-by":"crossref","unstructured":"Etzerodt A, Moulin M, Doktor T, Delfini M, Mossadegh-Keller N, Bajenoff M, et al (2020) Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J Exp Med 217(4)","DOI":"10.1084\/jem.20191869"},{"issue":"29","key":"5328_CR35","doi-asserted-by":"publisher","first-page":"eadg2697","DOI":"10.1126\/sciadv.adg2697","volume":"9","author":"S Han","year":"2023","unstructured":"Han S, Bao X, Zou Y, Wang L, Li Y, Yang L et al (2023) d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Sci Adv 9(29):eadg2697","journal-title":"Sci Adv"},{"key":"5328_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.canlet.2017.10.037","volume":"413","author":"RT Netea-Maier","year":"2018","unstructured":"Netea-Maier RT, Smit JWA, Netea MG (2018) Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship. Cancer Lett 413:102\u2013109","journal-title":"Cancer Lett"},{"issue":"11","key":"5328_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tcb.2023.03.008","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu J, Cao X (2023) Glucose metabolism of TAMs in tumor chemoresistance and metastasis. Trends Cell Biol 33(11):967\u2013978","journal-title":"Trends Cell Biol"},{"issue":"1","key":"5328_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36\u201350","journal-title":"Cell Metab"},{"key":"5328_CR39","doi-asserted-by":"crossref","unstructured":"Ohshima K, Morii E (2021) Metabolic reprogramming of cancer cells during tumor progression and metastasis. Metabolites 11(1)","DOI":"10.3390\/metabo11010028"},{"key":"5328_CR40","doi-asserted-by":"crossref","unstructured":"Gong Z, Li Q, Shi J, Liu ET, Shultz LD, Ren G (2022) Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. Cell Metab 34(12)","DOI":"10.1016\/j.cmet.2022.11.003"},{"issue":"5","key":"5328_CR41","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/HEP.0000000000000005","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y et al (2023) Metabolic reprogramming and its clinical implication for liver cancer. Hepatology 78(5):1602\u20131624","journal-title":"Hepatology"},{"issue":"1","key":"5328_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-020-01802-9","volume":"39","author":"S Zhao","year":"2020","unstructured":"Zhao S, Zhang X, Shi Y, Cheng L, Song T, Wu B et al (2020) MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer. J Exp Clin Cancer Res 39(1):286","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"5328_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41423-022-00925-7","volume":"19","author":"X Shan","year":"2022","unstructured":"Shan X, Hu P, Ni L, Shen L, Zhang Y, Ji Z et al (2022) Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis. Cell Mol Immunol 19(11):1263\u20131278","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"5328_CR44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798\u2013809","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"5328_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB (2018) IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol 18(9):545\u2013558","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5328_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","volume":"23","author":"C Deng","year":"2024","unstructured":"Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W et al (2024) Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer 23(1):49","journal-title":"Mol Cancer"},{"key":"5328_CR47","doi-asserted-by":"publisher","first-page":"112296","DOI":"10.1016\/j.mce.2024.112296","volume":"592","author":"HS Silveira","year":"2024","unstructured":"Silveira HS, Ces\u00e1rio RC, V\u00edgaro RA, Gaiotte LB, Cucielo MS, Guimar\u00e3es F et al (2024) Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells. Mol Cell Endocrinol 592:112296","journal-title":"Mol Cell Endocrinol"},{"key":"5328_CR48","doi-asserted-by":"publisher","first-page":"1030831","DOI":"10.3389\/fimmu.2022.1030831","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhou X, Ni Y, Zhao X, Liang X (2022) Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: a novel orientation for immunotherapy. Front Immunol 13:1030831","journal-title":"Front Immunol"},{"issue":"2","key":"5328_CR49","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1002\/mco2.245","volume":"4","author":"F Xie","year":"2023","unstructured":"Xie F, Zhang H, Zhu K, Jiang C-S, Zhang X, Chang H et al (2023) PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1. MedComm 4(2):e245","journal-title":"MedComm"},{"issue":"1","key":"5328_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ouyang F, Gao A, Zeng T, Li M, Li H et al (2024) ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. Mol Cancer 23(1):94","journal-title":"Mol Cancer"},{"key":"5328_CR51","doi-asserted-by":"publisher","first-page":"108327","DOI":"10.1016\/j.compbiomed.2024.108327","volume":"173","author":"Y Fu","year":"2024","unstructured":"Fu Y, Wang C, Wu Z, Zhang X, Liu Y, Wang X et al (2024) Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics. Comput Biol Med 173:108327","journal-title":"Comput Biol Med"},{"key":"5328_CR52","doi-asserted-by":"crossref","unstructured":"Mimouni NEH, Paiva I, Barbotin A-L, Timzoura FE, Plassard D, Le Gras S, et al (2021) Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab 33(3)","DOI":"10.1016\/j.cmet.2021.01.004"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05328-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:47:51Z","timestamp":1760168871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05328-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05328-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All human tissues and clinical information were collected using protocols approved by the Ethics Committee of Guangdong Provincial People's Hospital (KY-Z-2021-400-05). Written informed consent was obtained from all the patients. All animal procedures used in the study were approved by the Animal Ethics Committee of Guangdong Provincial People\u2019s Hospital (S2024-678-02).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}